W
William E. Boden
Researcher at University at Buffalo
Publications - 106
Citations - 9104
William E. Boden is an academic researcher from University at Buffalo. The author has contributed to research in topics: Coronary artery disease & Medicine. The author has an hindex of 30, co-authored 70 publications receiving 8249 citations. Previous affiliations of William E. Boden include Hartford Hospital & University of Connecticut.
Papers
More filters
Journal ArticleDOI
Current Use of Aspirin and Antithrombotic Agents in the United States Among Outpatients With Atherothrombotic Disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)
Christopher P. Cannon,Karen E. Rhee,Robert M. Califf,William E. Boden,Alan T. Hirsch,Mark J. Alberts,Greg Cable,Mingyuan Shao,E. Magnus Ohman,P. Gabriel Steg,Kim A. Eagle,Deepak L. Bhatt +11 more
TL;DR: Female gender, current smoking, or having diabetes mellitus were predictors of a lack of antithrombotic use; white race, atrial fibrillation or vascular disease, the use of other risk-reducing medications, or treatment by a cardiologist were associated with a greater likelihood of receiving antithROMbotic therapy.
Journal ArticleDOI
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease A Pre-Specified Subset Analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) Trial
Koon K. Teo,Steven P. Sedlis,William E. Boden,Robert A. O'Rourke,David J. Maron,Pamela M. Hartigan,Marcin Dada,Vipul Gupta,John A. Spertus,William J. Kostuk,Daniel S. Berman,Leslee J. Shaw,Bernard R. Chaitman,G.B. John Mancini,William S. Weintraub,Courage Trial Investigators +15 more
TL;DR: Data from the COURAGE trial support adherence to American College of Cardiology/American Heart Association clinical practice guidelines that advocate OMT as an appropriate initial management strategy, regardless of age.
Journal ArticleDOI
Patterns of transfer for patients with non–ST-segment elevation acute coronary syndrome from community to tertiary care hospitals
Matthew T. Roe,Anita Y. Chen,Elizabeth R. DeLong,William E. Boden,James E. Calvin,Charles B. Cairns,Sidney C. Smith,Charles Pollack,Ralph G. Brindis,Robert M. Califf,W. Brian Gibler,E. Magnus Ohman,Eric D. Peterson +12 more
TL;DR: Most patients with NSTE ACS presenting to community hospitals without revascularization capabilities are not rapidly transferred to tertiary hospitals, and lower-risk patients appear to be preferentially transferred early.
Journal ArticleDOI
Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery.
James S. Kalus,Michael F. Caron,C Michael White,Jeffrey Mather,Robert Gallagher,William E. Boden,Jeffrey Kluger +6 more
TL;DR: It is observed that fluid balance and volume administered on postoperative day 2 was greater in patients who developed postoperative atrial fibrillation than in those who did not.
Journal ArticleDOI
Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy: Observations From the COURAGE Trial
G.B. John Mancini,Pamela M. Hartigan,Eric R. Bates,Steven P. Sedlis,David J. Maron,John A. Spertus,Daniel S. Berman,William J. Kostuk,Leslee J. Shaw,William S. Weintraub,Koon K. Teo,Marcin Dada,Bernard R. Chaitman,Robert A. O'Rourke,William E. Boden +14 more
TL;DR: Lesions originally <50% DS were index lesions in one third of patients referred for symptom-driven repeat angiography, but represented <4% of all such lesions, which underscore the need for improved therapies to arrest plaque progression and reliable strategies for selecting stenoses warranting PCI.